Beurer
GL48/GL49
37
Concentration of
tested substances
50-100 mg/dL
(2.8-5.6 mmol/L)
250-350 mg/dL
(13.9-19.4 mmol/L)
Tolazamide
6.25 mg/dL
(0.35 mmol/L)
5.8 mg/dL
(0.32 mmol/L)
6.3%
Triglyceride
3000 mg/dL (166.59 mmol/L)
5.6 mg/dL
(0.31 mmol/L)
6.5%
Uric acid
10 mg/dL
(0.56 mmol/L)
5.4 mg/dL
(0.3 mmol/L)
5.6%
Xylose
6.25 mg/dL
(0.35 mmol/L)
5.5 mg/dL
(0.31 mmol/L)
7.3%
12. i
nstructions
for
use
for
the
lancinG
device
ld 04
12.1 Proper use
Indication/clinical benefits
The lancing device, in combination with a lancet needle, is intended for taking a blood sample for meas-
uring glucose levels in human blood. Use the lancing device only on the skin areas intended for taking the
glucose measurement (fingertips).
Contraindications
Use the lancing device only on the body parts listed in these instructions for use. Never use the lancing
device on injured, inflamed or scarred skin. Never use the lancing device on areas already affected by a
sensory disorder. If you drop the lancing device with an inserted lancet needle, carefully pick it up and dis-
pose of the lancet. Change the puncture area each time you take a measurement, e.g. use a different finger
or the other hand. Repeatedly using the same area may cause inflammation, numbness or scarring. Make
sure the puncture area is hygienically clean.
Blood glucose
value
Influence
